TRACING THE OUTBREAK
Amplifiers of JE
DOMINANT FORM OF ANTHRAX IN REGION 2
GI
MONOCLONAL ANTIBODY FOR TREATMENT AND PEP OF INHALATIONAL ANTHRAX
OBILTOXAXIMAB/NYXTHRACIS
DIAGNOSTIC GOLD STANDARD FOR JE
CSF IgM
SINGLE MOST EFFECTIVE INTERVENTION FOR JE
VACCINATION
DEPTH OF SOIL WHERE SPORES ARE FOUND
0-20 cm
CHEST RADIOLOGIC FINDING IN INHALATIONAL ANTHRAX
WIDENED MEDIASTINUM
DURATION OF TREATMENT FOR INTESTINAL ANTHRAX USING THE 2 IV ANTIBIOTICS.
14 DAYS
Due to its high pathogenicity and potential for aerosol transmission, anthrax is considered as biosafety level?
BSL 3
THE OCCUPATION WITH INCREASED RISK OF JE DUE TO EXPOSURE TO AN AMPLIFYING HOST
PIG FARMER
PERCENTAGE OF MORTALITY OF JE
30%
BRAIN REGION AFFECTED BY HSV
TEMPORAL LOBE
THE PRIMARY TREATMENT FOR JE IS....
SUPPORTIVE CARE
TRUE OR FALSE
THE MOST CONSISTENT FINDING ON MRI FOR JE IS BILATERAL INCREASED T4 SIGNAL ABNORMALITY IN THE THALAMUS WITH OR WITHOUT HEMORRHAGE
FALSE - T2
TRUE OR FALSE
CULLING OF INFECTED ANIMAL ERADICATES ANTHRAX BACTERIA AND ITS SPORED
FALSE
ETIOLOGIC TRIAD OF JE/ JE HOTSPOT
MOSQUITO/PIGS/RICE FIELDS
AGE RANGE OF CHILDREN MOST AFFECTED WITH SEVERE CASE OF JE
<15 YO
INCREASED INTRACRANIAL PRESSURE IN SEVERE JE MAY BE MANAGED WITH ....
MANNITOL
GIVE 3 DIFFERENTIAL DIAGNOSES OF JE
HSV
DENGUE
ENTEROVIRUS
DURATION OF PEP FOR ANTHRAX
60 DAYS
HOTSPOT AREAS OF ANTHRAX IN CAGAYAN PROVINCE - GIVE 2
STO. NINO
AMULUNG
CSF LAB FINDINGS IN JE
INCREASED LYMPHOCYTES
INCREASED PROTEIN
DOC for intestinal Anthrax
IV CIPROFLOXACIN + CLINDAMYCIN
GROWTH CHARACTERISTICS OF ANTHRAX(GIVE 3)
MEDUSSA HEAD
FROSTED GLASS APPEARANCE
STRING OF PEARLS
GIVE AT LEAST 3 WAYS ON HOW TO COMBAT JE TRANSMISSION
USING KULAMBO
FOGGING
USING MOSQUITO REPELLANT